|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Favoriti P, Carbone G, Greco M, Pirozzi F,
Pirozzi RE and Corcione F: Worldwide burden of colorectal cancer: A
review. Updates Surg. 68:7–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Zuo T, Zeng H, Zhang S
and He J: National cancer incidence and mortality in China, 2012.
Chin J Cancer Res. 28:1–11. 2016.PubMed/NCBI
|
|
4
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Anaya DA, Becker NS and Abraham NS: Global
graying, colorectal cancer and liver metastasis: New implications
for surgical management. Crit Rev Oncol Hematol. 77:100–108. 2011.
View Article : Google Scholar
|
|
6
|
Stein U and Schlag PM: Clinical,
biological, and molecular aspects of metastasis in colorectal
cancer. Recent Results Cancer Res. 176:61–80. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cancer Genome Atlas, N; Cancer Genome and
Atlas Network: Comprehensive molecular characterization of human
colon and rectal cancer. Nature. 487:330–337. 2012. View Article : Google Scholar
|
|
8
|
Uchi R, Takahashi Y, Niida A, Shimamura T,
Hirata H, Sugimachi K, Sawada G, Iwaya T, Kurashige J, Shinden Y,
et al: Integrated multiregional analysis proposing a new model of
colorectal cancer evolution. PLoS Genet. 12:pp. e10057782016,
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hirokawa N, Noda Y, Tanaka Y and Niwa S:
Kinesin superfamily motor proteins and intracellular transport. Nat
Rev Mol Cell Biol. 10:682–696. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miki H, Setou M, Kaneshiro K and Hirokawa
N: All kinesin superfamily protein, KIF, genes in mouse and human.
Proc Natl Acad Sci USA. 98:7004–7011. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hirokawa N and Tanaka Y: Kinesin
superfamily proteins (KIFs): Various functions and their relevance
for important phenomena in life and diseases. Exp Cell Res.
334:16–25. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lawrence CJ, Dawe RK, Christie KR,
Cleveland DW, Dawson SC, Endow SA, Goldstein LS, Goodson HV,
Hirokawa N, Howard J, et al: A standardized kinesin nomenclature. J
Cell Biol. 167:19–22. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nakagawa T, Tanaka Y, Matsuoka E, Kondo S,
Okada Y, Noda Y, Kanai Y and Hirokawa N: Identification and
classification of 16 new kinesin superfamily (KIF) proteins in
mouse genome. Proc Natl Acad Sci USA. 94:9654–9659. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bassi ZI, Audusseau M, Riparbelli MG,
Callaini G and D’Avino PP: Citron kinase controls a molecular
network required for midbody formation in cytokinesis. Proc Natl
Acad Sci USA. 110:9782–9787. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Arora K, Talje L, Asenjo AB, Andersen P,
Atchia K, Joshi M, Sosa H, Allingham JS and Kwok BH: KIF14 binds
tightly to microtubules and adopts a rigor-like conformation. J Mol
Biol. 426:2997–3015. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gruneberg U, Neef R, Li X, Chan EH,
Chalamalasetty RB, Nigg EA and Barr FA: KIF14 and citron kinase act
together to promote efficient cytokinesis. J Cell Biol.
172:363–372. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Watanabe S, De Zan T, Ishizaki T and
Narumiya S: Citron kinase mediates transition from constriction to
abscission through its coiled-coil domain. J Cell Sci.
126:1773–1784. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Molina I, Baars S, Brill JA, Hales KG,
Fuller MT and Ripoll P: A chromatin-associated kinesin-related
protein required for normal mitotic chromosome segregation in
Drosophila. J Cell Biol. 139:1361–1371. 1997. View Article : Google Scholar
|
|
19
|
Carleton M, Mao M, Biery M, Warrener P,
Kim S, Buser C, Marshall CG, Fernandes C, Annis J and Linsley PS:
RNA interference-mediated silencing of mitotic kinesin KIF14
disrupts cell cycle progression and induces cytokinesis failure.
Mol Cell Biol. 26:3853–3863. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu C, Zhao J, Bibikova M, Leverson JD,
Bossy-Wetzel E, Fan JB, Abraham RT and Jiang W: Functional analysis
of human microtubule-based motor proteins, the kinesins and
dyneins, in mitosis/cytokinesis using RNA interference. Mol Biol
Cell. 16:3187–3199. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moawia A, Shaheen R, Rasool S, Waseem SS,
Ewida N, Budde B, Kawalia A, Motameny S, Khan K, Fatima A, et al:
Mutations of KIF14 cause primary microcephaly by impairing
cytokinesis. Ann Neurol. 82:562–577. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Makrythanasis P, Maroofian R,
Stray-Pedersen A, Musaev D, Zaki MS, Mahmoud IG, Selim L, Elbadawy
A, Jhangiani SN, Coban Akdemir ZH, et al: Biallelic variants in
KIF14 cause intellectual disability with microcephaly. Eur J Hum
Genet. 26:330–339. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang W, Wang J, Zhang D, Chen W, Hou L,
Wu X and Lu Y: Inhibition of KIF14 suppresses tumor cell growth and
promotes apoptosis in human glioblastoma. Cell Physiol Biochem.
37:1659–1670. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Corson TW, Zhu CQ, Lau SK, Shepherd FA,
Tsao MS and Gallie BL: KIF14 messenger RNA expression is
independently prognostic for outcome in lung cancer. Clin Cancer
Res. 13:3229–3234. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu H, Choe C, Shin SH, Park SW, Kim HS,
Jung SH, Yim SH, Kim TM and Chung YJ: Silencing of KIF14 interferes
with cell cycle progression and cytokinesis by blocking the
p27(Kip1) ubiquitination pathway in hepatocellular carcinoma. Exp
Mol Med. 46:pp. e972014, View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Abiatari I, DeOliveira T, Kerkadze V,
Schwager C, Esposito I, Giese NA, Huber P, Bergman F, Abdollahi A,
Friess H, et al: Consensus transcriptome signature of perineural
invasion in pancreatic carcinoma. Mol Cancer Ther. 8:1494–1504.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Singel SM, Cornelius C, Zaganjor E, Batten
K, Sarode VR, Buckley DL, Peng Y, John GB, Li HC, Sadeghi N, et al:
KIF14 promotes AKT phosphorylation and contributes to
chemoresistance in triple-negative breast cancer. Neoplasia. 16:pp.
247–256. pp. 256.e2422014, https://doi.org/10.1016/j.neo.2014.03.008.
10.1016/j.neo.2014.03.008.
|
|
28
|
Corson TW and Gallie BL: KIF14 mRNA
expression is a predictor of grade and outcome in breast cancer.
Int J Cancer. 119:1088–1094. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Singel SM, Cornelius C, Batten K, Fasciani
G, Wright WE, Lum L and Shay JW: A targeted RNAi screen of the
breast cancer genome identifies KIF14 and TLN1 as genes that
modulate docetaxel chemosensitivity in triple-negative breast
cancer. Clin Cancer Res. 19:2061–2070. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thériault BL, Cybulska P, Shaw PA, Gallie
BL and Bernardini MQ: The role of KIF14 in patient-derived primary
cultures of high-grade serous ovarian cancer cells. J Ovarian Res.
7:1232014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thériault BL, Pajovic S, Bernardini MQ,
Shaw PA and Gallie BL: Kinesin family member 14: An independent
prognostic marker and potential therapeutic target for ovarian
cancer. Int J Cancer. 130:1844–1854. 2012. View Article : Google Scholar
|
|
32
|
Corson TW, Huang A, Tsao MS and Gallie BL:
KIF14 is a candidate oncogene in the 1q minimal region of genomic
gain in multiple cancers. Oncogene. 24:4741–4753. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kumar S, Nag A and Mandal CC: A
Comprehensive Review on miR-200c, a promising cancer biomarker with
therapeutic potential. Curr Drug Targets. 16:1381–1403. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mutlu M, Raza U, Saatci Ö, Eyüpoğlu E,
Yurdusev E and Şahin Ö: miR-200c: A versatile watchdog in cancer
progression, EMT, and drug resistance. J Mol Med (Berl).
94:629–644. 2016. View Article : Google Scholar
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
36
|
Shin G, Kang TW, Yang S, Baek SJ, Jeong YS
and Kim SY: GENT: Gene expression database of normal and tumor
tissues. Cancer Inform. 10:149–157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES, et al: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mootha VK, Lindgren CM, Eriksson KF,
Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E,
Ridderstråle M, Laurila E, et al: PGC-1alpha-responsive genes
involved in oxidative phosphorylation are coordinately
downregulated in human diabetes. Nat Genet. 34:267–273. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multi- dimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mermel CH, Schumacher SE, Hill B, Meyerson
ML, Beroukhim R and Getz G: GISTIC2.0 facilitates sensitive and
confident localization of the targets of focal somatic copy-number
alteration in human cancers. Genome Biol. 12:R412011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Betel D, Wilson M, Gabow A, Marks DS and
Sander C: The http://microRNA.orgurisimplemicroRNA.org resource:
Targets and expression. Nucleic Acids Res. 36:Database. pp.
D149–D153. 2008, View Article : Google Scholar
|
|
43
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li LT, Jiang G, Chen Q and Zheng JN: Ki67
is a promising molecular target in the diagnosis of cancer
(Review). Mol Med Rep. 11:1566–1572. 2015. View Article : Google Scholar
|
|
45
|
Liu P, Begley M, Michowski W, Inuzuka H,
Ginzberg M, Gao D, Tsou P, Gan W, Papa A, Kim BM, et al:
Cell-cycle-regulated activation of Akt kinase by phosphorylation at
its carboxyl terminus. Nature. 508:541–545. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liang J and Slingerland JM: Multiple roles
of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell
Cycle. 2:339–345. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Thériault BL, Basavarajappa HD, Lim H,
Pajovic S, Gallie BL and Corson TW: Transcriptional and epigenetic
regulation of KIF14 overexpression in ovarian cancer. PLoS One.
9:pp. e915402014, View Article : Google Scholar : PubMed/NCBI
|
|
48
|
O’Brien SJ, Carter JV, Burton JF, Oxford
BG, Schmidt MN, Hallion JC and Galandiuk S: The role of the miR-200
family in epithelial-mesenchymal transition in colorectal cancer: A
systematic review. Int J Cancer. 142:2501–2511. 2018. View Article : Google Scholar
|
|
49
|
Tian Y, Pan Q, Shang Y, Zhu R, Ye J, Liu
Y, Zhong X, Li S, He Y, Chen L, et al: MicroRNA-200 (miR-200)
cluster regulation by achaete scute-like 2 (Ascl2): Impact on the
epithelial- mesenchymal transition in colon cancer cells. J Biol
Chem. 289:36101–36115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lu YX, Yuan L, Xue XL, Zhou M, Liu Y,
Zhang C, Li JP, Zheng L, Hong M and Li XN: Regulation of colorectal
carcinoma stemness, growth, and metastasis by an
miR-200c-Sox2-negative feedback loop mechanism. Clin Cancer Res.
20:2631–2642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Toiyama Y, Hur K, Tanaka K, Inoue Y,
Kusunoki M, Boland CR and Goel A: Serum miR-200c is a novel
prognostic and metastasis-predictive biomarker in patients with
colorectal cancer. Ann Surg. 259:735–743. 2014. View Article : Google Scholar :
|
|
52
|
Wang M, Zhang P, Li Y, Liu G, Zhou B, Zhan
L, Zhou Z and Sun X: The quantitative analysis by stem-loop
real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-
200c overexpression in human colorectal cancer. Med Oncol.
29:3113–3118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar :
|
|
54
|
Pan Q, Meng L, Ye J, Wei X, Shang Y, Tian
Y, He Y, Peng Z, Chen L, Chen W, et al: Transcriptional repression
of miR-200 family members by Nanog in colon cancer cells induces
epithelial-mesenchymal transition (EMT). Cancer Lett. 392:26–38.
2017. View Article : Google Scholar : PubMed/NCBI
|
